Literature DB >> 16723989

Brain tumour stem cells.

Angelo L Vescovi1, Rossella Galli, Brent A Reynolds.   

Abstract

The dogma that the genesis of new cells is a negligible event in the adult mammalian brain has long influenced our perception and understanding of the origin and development of CNS tumours. The discovery that new neurons and glia are produced throughout life from neural stem cells provides new possibilities for the candidate cells of origin of CNS neoplasias. The emerging hypothesis is that alterations in the cellular and genetic mechanisms that control adult neurogenesis might contribute to brain tumorigenesis, thereby allowing the identification of new therapeutic strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16723989     DOI: 10.1038/nrc1889

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  396 in total

Review 1.  Stem cell niche irradiation in glioblastoma: providing a ray of hope?

Authors:  Tejpal Gupta; Vimoj Nair; Rakesh Jalali
Journal:  CNS Oncol       Date:  2014

2.  MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.

Authors:  Chao Shang; Yan Guo; Yang Hong; Yun-hui Liu; Yi-xue Xue
Journal:  Mol Biol Rep       Date:  2014-11-14       Impact factor: 2.316

3.  Evidence for label-retaining tumour-initiating cells in human glioblastoma.

Authors:  Loic P Deleyrolle; Angus Harding; Kathleen Cato; Florian A Siebzehnrubl; Maryam Rahman; Hassan Azari; Sarah Olson; Brian Gabrielli; Geoffrey Osborne; Angelo Vescovi; Brent A Reynolds
Journal:  Brain       Date:  2011-04-22       Impact factor: 13.501

4.  PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas.

Authors:  Hongwu Zheng; Haoqiang Ying; Ruprecht Wiedemeyer; Haiyan Yan; Steven N Quayle; Elena V Ivanova; Ji-Hye Paik; Hailei Zhang; Yonghong Xiao; Samuel R Perry; Jian Hu; Anant Vinjamoori; Boyi Gan; Ergun Sahin; Milan G Chheda; Cameron Brennan; Y Alan Wang; William C Hahn; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

5.  Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.

Authors:  J M Heddleston; Q Wu; M Rivera; S Minhas; J D Lathia; A E Sloan; O Iliopoulos; A B Hjelmeland; J N Rich
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 6.  Stem cells in the nervous system.

Authors:  Angel R Maldonado-Soto; Derek H Oakley; Hynek Wichterle; Joel Stein; Fiona K Doetsch; Christopher E Henderson
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

7.  Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.

Authors:  Liang Leng; Xiaojun Zhong; Guan Sun; Wen Qiu; Lei Shi
Journal:  Tumour Biol       Date:  2016-10-18

8.  EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.

Authors:  Qi Yu; Libo Liu; Ping Wang; Yilong Yao; Yixue Xue; Yunhui Liu
Journal:  Cell Cycle       Date:  2017-04-24       Impact factor: 4.534

9.  Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs.

Authors:  Guangzhong Xu; Kai Li; Nengwei Zhang; Bin Zhu; Guosheng Feng; Qing Fan
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

10.  Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.

Authors:  Wensheng Yang; Mariana Cooke; Colin S Duckett; Xiaolu Yang; Jay F Dorsey
Journal:  Cell Cycle       Date:  2014-01-22       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.